Staff

Allen Minns

Research Technologist IV - Lindner Lab

Email amm504@psu.edu
Phone (814) 867-4107

Centers & Institutes

Center for Infectious Disease Dynamics

Researchers have demonstrated proof-of-principle of a protein-based intranasal vaccine platform, called SpyCage, that could eventually help to prevent infection and transmission of respiratory viruses, like SARS-CoV-2. Image shows an illustration of the SpyCage vaccine platform, on right, decorated with a portion of the spike protein from SARS-CoV-2, next to an illustration of the virus. Credit: Dani Zemba / Penn State. Creative Commons

March 12, 2024

New nasal vaccine platform helps clear COVID-19 infections in an animal model

Legal Statements